Major Pharmaceuticals Unit-Dose Triple Antibiotic Ointment (NDC 00904-8805-67) provides comprehensive, broad-spectrum topical first-aid protection engineered to help prevent bacterial infection in minor cuts, scrapes, and burns across institutional healthcare facilities, surgical units, and emergency response stations. Formulated with a synergistic combination of three active antibiotics—bacitracin zinc, neomycin sulfate, and polymyxin B sulfate—in a protective petrolatum base, this antimicrobial ointment inhibits protein synthesis across a wide range of Gram-positive and Gram-negative pathogens. Packaged in individual 0.9-gram unit-dose foil packets (144 packets per box, 12 boxes per case), this product eliminates cross-contamination risks, streamlines bedside wound care protocols, and optimizes central supply inventory management across hospitals, urgent care clinics, and long-term care facilities.
-
Labeled First Aid Active – Formulated with neomycin sulfate and bacitracin zinc and polymyxin b sulfate as named on the package panel for this first aid antibiotic.
-
Kit Ready Packaging – The package format suits first aid kits, treatment rooms and restock bins, in Ointment, 0.9 g Unit Dose Packets, 144 Count.
-
Package Configurations – Sold as listed in Ointment, 0.9 g Unit Dose Packets, 144 Count, with each configuration priced from its own packaged cost.
